Navigation Links
Drug interactions causing a significant impact on statin use
Date:11/25/2013

CORVALLIS, Ore. A new study has found that many people who stopped taking cholesterol-lowering statin drugs were also taking an average of three other drugs that interfered with the normal metabolism of the statins.

The other drugs can contribute to a common side effect of taking statins - muscle pain and often led people to discontinue use of a medication that could otherwise help save their life, researchers learned.

The interactions of many drugs with statins have been known of for some time, researchers said, but are not being adequately managed by physicians and pharmacists, who could often choose different medications or adjust dosages to retain the value of statin drugs without causing this side effect.

The research, done as part of a survey of more than 10,000 current and former statin users, found that use of medications which interfere with statin metabolism almost doubles the chance that a person will discontinue statin use due to muscle pain.

The issue is of growing importance because statin drugs are some of the most widely used medications in the world, proven to lower LDL, or "bad" cholesterol, and decrease the risk of heart attacks, heart disease, strokes and death. About 20 million people in the U.S. now take statins, and new guidelines have just been issued to further expand the types of health conditions for which statins may be of benefit. Based on those guidelines, the number of statin users could increase to more than 30 million.

The findings were published in the Journal of Clinical Lipidology by scientists from Oregon State University and four other universities or research institutes.

"We've known for some time of many medications that can interact with statins, but only now is it becoming clear that this is a significant contributor to the side effects, and often the reason some patients stop taking statins," said Matt Ito, a professor in the OSU College of Pharmacy and pre
'/>"/>

Contact: Matt Ito
itom@ohsu.edu
503-494-3657
Oregon State University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Gene combinations and interactions affect risk of Crohns disease
2. Interactions between drugs can also be measured at lowest doses
3. Survey shows medical students have frequent interactions with pharmaceutical companies
4. Stanford/Intel study details power of new chip to diagnose disease, analyze protein interactions
5. Novel technique demonstrates interactions between malaria parasite and HIV
6. Child Has Surgery at Wolfson Children's Hospital to Disconnect Left from Right Brain to Help Control Condition Causing Hundreds of Seizures a Day
7. Climate Change Causing Increased Air Pollution Warns White Paper
8. Maternal smoking may impair infant immunity, causing a broad range of infections
9. Parker Waichman LLP Represents Wisconsin Woman in Lawsuit Alleging Mirena IUD Perforated her Uterus, Causing Serious Pain and Injuries
10. Over 600 Water Mains Break Every Day in the US Causing Nationwide Water Concerns
11. Poor oral health linked to cancer-causing oral HPV infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Mesa, Arizona (PRWEB) May 6, ... Ventures, Inc. (MAV), an investor backed Colorado cannabis ... based Phoenician Engineering subsidiary three times since first ... achieved profitability from operations, within one year of ... the end of 2014 to over 500 today ...
(Date:5/6/2015)... The American Water Resources Association (AWRA) announces ... Integrated Water Resources Management (IWRM) award , recognizing excellence in ... , An IWRM approach to water resources has been a ... 12 projects were nominated for the award. The May issue ... 2014 AWRA IWRM Award winner - One Water, One Watershed ...
(Date:5/6/2015)... NC (PRWEB) May 06, 2015 Doctors ... recently reported what they are calling “unprecedented” tumor control ... article on the new research. Click here to ... gave pembrolizumab to 25 mesothelioma patients between March and ... meeting in April. , “Pembrolizumab… provides robust antitumor activity ...
(Date:5/6/2015)... May 06, 2015 ProTrailer Cartoon Volume ... self-animating generators for Final Cut Pro X . ... titles to a Final Cut Pro X project.It includes ... quality openers to any shot has never been easier. ... in mind, saving users time while adding amazing openers ...
(Date:5/6/2015)... Omaha, NE (PRWEB) May 06, 2015 The ... to a nationwide nursing shortage to an increase in educational ... Aureus Medical Group , offers insight on these trends ... most of the multitude of opportunities that exist in the ... , Widespread electronic health record implementation has been prevalent across ...
Breaking Medicine News(10 mins):Health News:Cannibus Industry Start-Up Reaches Profitability While Expanding Its Proprietary Ancillary Medical Marijuana Product IP Portfolio 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Researchers Say “Unprecedented” Mesothelioma Response Possible with Skin Cancer Drug, According to Surviving Mesothelioma 2Health News:Pixel Film Studios announces the release of Protrailer Cartoon Volume 2 for Final Cut Pro X. 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 3Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 4
... by Regulatory Approval of Once-Daily Tramadol in, ... for Depression -,LAVAL, QC, Feb. 26 /PRNewswire-FirstCall/ - Labopharm Inc. ... results for the fourth quarter and year ended December 31, ... , "With our first product about to be rolled out ...
... global rare disease community to raise awareness for underserved ... Feb. 26 Shire Human Genetic Therapies (HGT), a ... company, today announced it will join together with the ... Rare Disease Day on February 28, 2009. The purpose ...
... ST. LOUIS, Feb. 26 Stereotaxis, Inc.,(Nasdaq: ... fourth quarter,ended December 31, 2008. Revenue for the ... 18% over the fourth quarter of 2007. Stereotaxis,recognized ... systems in the quarter. Revenue from sales of ...
... 26 MIND Research Institute today,announced that Jim Mazzo, ... was recently elected to MIND,s board of directors. Mr.,Mazzo ... numerous boards and,committees at the University of California ... of Trustees, the Engineering Advisory Board Committee, and,the Eye ...
... Prestigious AwardsLONDON, Feb. 26 The Healthcare ... Frost & Sullivan,s ,Excellence in Healthcare Awards ... London Zoo, London. The industry,s most influential ... their achievements during an evening dinner gala.(Logo: ...
... Footwear by BeechHUNTINGTON BEACH, Calif., Feb. 26 ... Originals line with new adjustable toe separators ... foot therapy can now be customized to fit ... increasing flexibility and helping improve balance and body ...
Cached Medicine News:Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 2Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 3Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 4Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 5Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 6Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 7Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 8Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 9Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 10Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 11Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 12Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 13Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 14Health News:Shire Celebrates World Rare Disease Day on February 28 2Health News:Shire Celebrates World Rare Disease Day on February 28 3Health News:Shire Celebrates World Rare Disease Day on February 28 4Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 2Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 3Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 4Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 5Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 6Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 7Health News:Jim Mazzo Joins MIND Research Institute's Board of Directors 2Health News:Frost & Sullivan Awards to Celebrate Healthcare Excellence 2Health News:Sandal Evolution(R) Takes a Healthy Step 2
(Date:5/6/2015)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ("Galmed"), ... commercialization of a once-daily, oral therapy for the treatment ... it will host a conference call and webcast on ... period ended March 31, 2015 and to provide an ... program for aramchol. Conference Call & ...
(Date:5/6/2015)... GERMANTOWN, Md. , May 6, 2015 ... neural stem cell technology to develop small molecule and ... the appointment of Jonathan Lloyd Jones to ... th . Mr. Lloyd Jones ... of corporate finance and business development experience.   Most recently, ...
(Date:5/6/2015)... 6, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ... for the three-month period ended March 31, 2015. First quarter ... million, an increase of 19% as compared to $7.0 ... Product revenues increased 41% year-over-year, enabled by the return ... Merck Serono in the fourth quarter of 2014; ...
Breaking Medicine Technology:Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11
... 26, 2007,/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , ... announced that,the two-year data from its European ... ("Vascular Wrap(TM)"),will be presented today at a ... the safety and efficacy of the Vascular,Wrap(TM) ...
... cord and other central,nervous system transplants possible, BOSTON, ... Eye Research Institute, an affiliate of Harvard Medical,School, ... into the adult central nervous system. The,study found ... induced by,stem cells) has the ability to break ...
Cached Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
... surgeons with brighter, crisper, magnified views of ... many minimally invasive spine procedures. It is ... of contact. The first graphical touchscreen to ... intuitive user guidance similar to that known ...
Micro Dissecting Curette, 5 1/2", Round....
14 cm, very delicate, round cupped jaws, straight jaws, 3.0 mm...
Wilson pituitary forcep, flattened tip, 3 mm bite, 145 mm effective....
Medicine Products: